top of page


  • Commercialization strategies, launch strategies, & tactical implementation support for rare disease and specialty drugs & gene therapies

  • Corporate value narratives for a rare disease orphan drug manufacturers.

  • Patient philosophies for a clinical stage rare and specialty companies

  • Patient & caregiver engagement strategies for a clinical-stage rare disease companies.

  • Creation of U.S. patient advocacy communities/platforms for rare orphan conditions

  • Drug pricing strategies, market access strategies and supporting value stories for multiple rare orphan and specialty manufacturers

  • Government & public affairs strategies and client representation with policymakers to optimize product launch and patient access

  • Federal and state legislative monitoring & client representation

  • Risk mitigation strategies

  • Strategic vision & engagement plan for health system pediatric innovation hub

  • Strategic portfolio review for a health system innovation hub

  • Business development/partnering for early stage and privately held orphan drug companies

bottom of page